Manifestation of symptoms
Pro Research Analysisby 
Searched over 200M research papers
Manifestation of Symptoms in COVID-19 Patients
Common Clinical Manifestations of COVID-19
COVID-19, caused by the SARS-CoV-2 virus, presents a wide array of clinical symptoms. The most frequently reported symptoms include fever, cough, dyspnea (shortness of breath), malaise, fatigue, and sputum production. These symptoms have been observed in over 25% of patients, with fever and cough being the most prevalent, affecting approximately 58.66% and 54.52% of patients, respectively . Other common symptoms include myalgia (muscle pain), headache, and gastrointestinal issues such as diarrhea .
Neurological Manifestations
Neurological symptoms are increasingly recognized as significant manifestations of COVID-19. Studies have identified a range of neurological symptoms, including central nervous system (CNS) manifestations like dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizures. Peripheral nervous system (PNS) symptoms such as taste and smell impairments, vision impairment, and nerve pain are also reported 157. A meta-analysis revealed that up to one-third of COVID-19 patients experience at least one neurological symptom, with fatigue, myalgia, taste impairment, and smell impairment being the most common 25.
Severity and Neurological Symptoms
The severity of COVID-19 appears to correlate with the prevalence of neurological symptoms. Patients with severe infections are more likely to exhibit acute cerebrovascular diseases, impaired consciousness, and skeletal muscle injury compared to those with non-severe infections . Additionally, older patients and those with underlying health conditions are at higher risk of experiencing severe neurological manifestations, which are also associated with increased mortality .
Dermatological Manifestations
COVID-19 can also present with various dermatological symptoms. The most common skin manifestations include maculopapular exanthem (morbilliform rash), papulovesicular rash, urticaria, and painful acral red-purple papules. These skin lesions typically appear on the trunk and, less frequently, on the hands and feet. They usually develop after the onset of respiratory symptoms and resolve within 10 days .
Extraintestinal Manifestations in IBS Patients
Patients with irritable bowel syndrome (IBS) often experience extraintestinal symptoms, which can be exacerbated by COVID-19. Common extraintestinal manifestations include somatic pain, fatigue, and sleep disturbances. These symptoms are more prevalent in women and are associated with increased gastrointestinal symptoms, psychological distress, and higher healthcare costs .
COVID-19 in Pregnant Women
Pregnant women with COVID-19 are less likely to report symptoms such as fever and myalgia compared to non-pregnant women of reproductive age. However, they are more likely to require intensive care and invasive ventilation. Risk factors for severe COVID-19 in pregnancy include advanced maternal age, high body mass index, chronic hypertension, and pre-existing diabetes. Pregnant women with COVID-19 also have higher rates of preterm birth, and their neonates are more likely to be admitted to neonatal units .
Conclusion
COVID-19 presents a diverse range of symptoms, affecting multiple systems in the body. Neurological and dermatological manifestations are significant and can vary in severity. Understanding these symptoms is crucial for timely diagnosis and effective management of the disease. Further research is needed to explore the underlying mechanisms and improve treatment strategies for COVID-19-related manifestations.
Sources and full results
Most relevant research papers on this topic